Fig. 3.
Effect of depletion of CD25+ cells on the negative regulatory activity of CD4+ T cells from the tolerant CBA mice.
(A) Each naive CBA mouse was treated with 2.5 × 106spleen CD4+ T cells with or without depletion of CD25+ cells from naive or tolerant CBA mice. No CD4+ T cells were given to the CBA mice in the control group (Control). Thereafter, all CBA mice were challenged with BALB/c PBMCs, and the development of anti–H-2d antibody was determined as described. Analysis of variance showed that only the mice treated with tolerant CD4+ T cells without depletion of CD25+ cells (Tol.CD4+ cells) had anti–H-2d antibody activity significantly lower than in the other 4 groups (P < .04). Anti–H-2dantibody activities in the CBA mice treated with tolerant CD4+ with depletion of CD25+ T cells (CD4+/CD25−) were not significantly different than in the control and in those treated with naive CD4+with or without depletion of CD25+ T cells (P ≥ .40). There were 4 mice in each group. (B) In a separate experiment, each naive CBA mouse was adoptively transferred with 5 × 106 spleen CD4+ T cells with or without depletion of CD25+ cells from naive CBA mice or CBA mice tolerant to BALB/c H-2d antigens. Adoptively transferred and control CBA mice were challenged with H-2b–positive BL/6 PBMCs, as described. Analysis of variance showed that only CBA mice adoptively transferred with the tolerant CD4+ T cells (Tol. CD4+ cells) developed anti–H-2b antibody activities significantly lower than in the other 3 groups (P ≤ .02). There were 4 mice in each group.